Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice is a research paper published in PLoS Pathogens (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 CA232616-02
National Institutes of Health
Grant: R01 AI147060-01A1
National Institutes of Health
Grant: R01 CA229673-01A1
National Institutes of Health
Grant: R01 CA022443-42
National Institutes of Health
Grant: R01 CA281379
National Institutes of Health
Grant: U01 CA284614
Cancer Research UK Cambridge Institute, University of Cambridge
Grant: RCCFEL∖100072
Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge
Grant: 203151/Z/16/Z
CRUK and EPSRC Cancer Imaging Centre in Cambridge and Manchester
Grant: A25117
NIHR Cambridge Biomedical Research Centre
Grant: BRC-1215-555 20014
NCI NIH HHS
Grant: R01 CA232616
Medical Research Council
Grant: MC_PC_17230
NIAID NIH HHS
Grant: R01 AI147060
NCI NIH HHS
Grant: R01 CA229673
NCI NIH HHS
Grant: P01 CA022443
NCI NIH HHS
Grant: T32 CA009135
National Institutes of Health
Grant: 1R01CA232616-01
EBV LMP1/LMP2A Proteins Promote Hodgkin-like Lymphomas in Humanized Mice
National Institutes of Health
Grant: 5R01CA229673-03
Role of EBV Lytic Infection in Viral Tumorigenesis
Wellcome Trust
Grant: 203151
Cambridge Stem Cell Institute
National Institutes of Health
Grant: 3P01CA022443-43S1
Developing and Applying a Safe, Tractable Derivative of SARS-CoV-2
National Institutes of Health
Grant: 1U01CA284614-01
Roles of LMP1 and MYC in EBV-induced B-cell tumors
National Institutes of Health
Grant: 5R01AI147060-05
Effects of EBV Type on Viral Reactivation
National Institutes of Health
Grant: 1R01CA281379-01
Stringent Latent Epstein-Barr Virus (EBV) Infection Collaborates with Cellular Gene Alterations to Induce EBV+ Lymphomas
Wellcome Trust
FWCI
1.62
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals